934 related articles for article (PubMed ID: 29482561)
1. Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy.
Sengar P; Juárez P; Verdugo-Meza A; Arellano DL; Jain A; Chauhan K; Hirata GA; Fournier PGJ
J Nanobiotechnology; 2018 Feb; 16(1):19. PubMed ID: 29482561
[TBL] [Abstract][Full Text] [Related]
2. Dual-photosensitizer coupled nanoscintillator capable of producing type I and type II ROS for next generation photodynamic therapy.
Sengar P; Garcia-Tapia K; Chauhan K; Jain A; Juarez-Moreno K; Borbón-Nuñez HA; Tiznado H; Contreras OE; Hirata GA
J Colloid Interface Sci; 2019 Feb; 536():586-597. PubMed ID: 30390584
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the emission spectra and cytotoxicity of TiO
Vejdani Noghreiyan A; Sazegar MR; Mousavi Shaegh SA; Sazgarnia A
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101770. PubMed ID: 32311544
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic application of protoporphyrin IX as a photosensitizer encapsulated by silica nanoparticles.
Makhadmeh GN; Abdul Aziz A
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1043-S1046. PubMed ID: 30449196
[TBL] [Abstract][Full Text] [Related]
5. Inorganic photosensitizer coupled Gd-based upconversion luminescent nanocomposites for in vivo magnetic resonance imaging and near-infrared-responsive photodynamic therapy in cancers.
Zhang L; Zeng L; Pan Y; Luo S; Ren W; Gong A; Ma X; Liang H; Lu G; Wu A
Biomaterials; 2015 Mar; 44():82-90. PubMed ID: 25617128
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of protoporphyrin IX performance in aqueous solutions for photodynamic therapy.
Homayoni H; Jiang K; Zou X; Hossu M; Rashidi LH; Chen W
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):258-66. PubMed ID: 25636780
[TBL] [Abstract][Full Text] [Related]
7. Design of a novel nanoparticle to use X-ray fluorescence of TiO
Noghreiyan AV; Soleymanifard S; Sazgarnia A
Photodiagnosis Photodyn Ther; 2024 Feb; 45():103890. PubMed ID: 37981223
[TBL] [Abstract][Full Text] [Related]
8. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
Mukai H; Wada Y; Watanabe Y
Ann Nucl Med; 2013 Aug; 27(7):625-39. PubMed ID: 23605059
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the in vitro and in vivo effects of photodynamic therapy on prostate cancer by using new photosensitizers, protoporphyrin IX-polyamine derivatives.
Fidanzi-Dugas C; Liagre B; Chemin G; Perraud A; Carrion C; Couquet CY; Granet R; Sol V; Léger DY
Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1676-1690. PubMed ID: 28188858
[TBL] [Abstract][Full Text] [Related]
10. Magnetic-luminescent cerium-doped gadolinium aluminum garnet nanoparticles for simultaneous imaging and photodynamic therapy of cancer cells.
Jain A; Koyani R; Muñoz C; Sengar P; Contreras OE; Juárez P; Hirata GA
J Colloid Interface Sci; 2018 Sep; 526():220-229. PubMed ID: 29734089
[TBL] [Abstract][Full Text] [Related]
11. 808 nm Light-triggered and hyaluronic acid-targeted dual-photosensitizers nanoplatform by fully utilizing Nd(3+)-sensitized upconversion emission with enhanced anti-tumor efficacy.
Hou Z; Deng K; Li C; Deng X; Lian H; Cheng Z; Jin D; Lin J
Biomaterials; 2016 Sep; 101():32-46. PubMed ID: 27267626
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
13. Nanocomposite-Based Photodynamic Therapy Strategies for Deep Tumor Treatment.
Hu J; Tang Y; Elmenoufy AH; Xu H; Cheng Z; Yang X
Small; 2015 Nov; 11(44):5860-87. PubMed ID: 26398119
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose X-ray Excited Photodynamic Therapy Based on NaLuF
Zhang X; Lan B; Wang S; Gao P; Liu T; Rong J; Xiao F; Wei L; Lu H; Pang C; Fan L; Zhang W; Lu H
Bioconjug Chem; 2019 Aug; 30(8):2191-2200. PubMed ID: 31344330
[TBL] [Abstract][Full Text] [Related]
15. Colloidal mesoporous silica nanoparticles with protoporphyrin IX encapsulated for photodynamic therapy.
Qian J; Gharibi A; He S
J Biomed Opt; 2009; 14(1):014012. PubMed ID: 19256700
[TBL] [Abstract][Full Text] [Related]
16. Protoporphyrin IX-gold nanoparticle conjugates as an efficient photosensitizer in cervical cancer therapy.
Eshghi H; Sazgarnia A; Rahimizadeh M; Attaran N; Bakavoli M; Soudmand S
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):304-12. PubMed ID: 23993857
[TBL] [Abstract][Full Text] [Related]
17. Annealing-modulated nanoscintillators for nonconventional X-ray activation of comprehensive photodynamic effects in deep cancer theranostics.
Chuang YC; Chu CH; Cheng SH; Liao LD; Chu TS; Chen NT; Paldino A; Hsia Y; Chen CT; Lo LW
Theranostics; 2020; 10(15):6758-6773. PubMed ID: 32550902
[TBL] [Abstract][Full Text] [Related]
18. Phospholipid-functionalized mesoporous silica nanocarriers for selective photodynamic therapy of cancer.
Teng IT; Chang YJ; Wang LS; Lu HY; Wu LC; Yang CM; Chiu CC; Yang CH; Hsu SL; Ho JA
Biomaterials; 2013 Oct; 34(30):7462-70. PubMed ID: 23810081
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence detection and depletion of T47D breast cancer cells from human mononuclear cell-enriched blood preparations by photodynamic treatment: Basic in vitro experiments towards the removal of circulating tumor cells.
Ziegler VG; Knaup J; Stahl D; Krammer B; Plaetzer K
Lasers Surg Med; 2011 Sep; 43(7):548-56. PubMed ID: 22057482
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded NaYF4:Yb/Tm-TiO2 inorganic photosensitizers for NIR-triggered photodynamic therapy and enhanced chemotherapy in drug-resistant breast cancers.
Zeng L; Pan Y; Tian Y; Wang X; Ren W; Wang S; Lu G; Wu A
Biomaterials; 2015 Jul; 57():93-106. PubMed ID: 25913254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
